For instance, a single injection of oAd/Cas12a targeting EGFR led to an 88.6% reduction in tumor volume in A549 xenograft mice, highlighting the high efficacy of oAd combined with CRISPR-Cas12a in tumor suppression [24]. Here, EGFR is linked to neoplasm.